Translational Development Acquisition Corp. (TDAC) is a blank check company incorporated in 2022 and headquartered in New York. It has no significant operations and was formed to effect a business combination with one or more operating businesses.
In May 2026, TDAC announced a definitive agreement for a business combination with ProLogium, a developer of fourth-generation solid-state lithium ceramic batteries. The transaction values ProLogium at approximately $3.8 billion pre-money and is expected to close in the second half of 2026, subject to shareholder and regulatory approvals. Upon completion, the combined company would list on Nasdaq under the ticker PRLG.
Official website: translational-development.com
To provide comprehensive coverage, we aggregate data and news under the name Translational Development Acquisition Corp., encompassing the following company names, divisions, and related entities:
TDAC and Translational Development Acquisition Corp. (TDAC).
This list encompasses current and former names, alternate names, and key divisions associated with Translational Development Acquisition Corp., ensuring you can easily find all relevant information under a single, unified profile.
